Adagrasib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of adagrasib that may be used in the treatment of KRAS G12C mutation-positive non-small cell lung cancer (NSCLC), ampullary, small bowel and pancreatic adenocarcinomas, biliary tract cancer, appendiceal cancer, and colorectal cancer.

**Synonyms:** - Adagrasib monotherapy - Krazati Regimen